Clinical trial
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects With Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
NCT03884257 is registered in ClinicalTrials.gov with KANDO Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects With Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
- Lead sponsor
- KANDO Research
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 18, 2020
- Completion date
- October 6, 2026
- Enrollment
- 302 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.